Drug utilization reviews revealed a mean of 4.6 interactions per patient in a population taking a mean of 14.7 medications, underscoring the pharmacological complexity that a structured, pharmacy-supported clinic may help address.
Cannabis-Based Spray Shows Early Safety Promise for Alzheimer’s Agitation—But Proof of Efficacy Still Awaited
Despite significant COVID-19 pandemic-related challenges, administering nabiximols through oral mucosa to advanced Alzheimer’s dementia patients with agitation demonstrated feasibility and safety. These findings support a larger confirmatory efficacy trial.
Small Pilot Trial Tests Medicinal Cannabis for Teen Tourette Syndrome—Finds Protocol Feasible, Efficacy Questions Remain
The findings suggest that the study protocol is feasible and acceptable to patients with TS and their families. A fully powered study is needed to evaluate the efficacy of MC in adolescent TS.
Topical Cannabis Balms for AIMSS: Clinical Trial Data
Clinical Takeaway Topical cannabis balms were tested in a randomized, open-label trial among postmenopausal women with hormone receptor-positive breast cancer who developed musculoskeletal pain and joint stiffness from aromatase inhibitor therapy. The...